文献速递核素与放射性配体治疗肿瘤 PET/CT

9岁儿童转移性颈动脉体副神经节瘤经177Lu-DOTATATE PRRT治疗达完全缓解

Complete Response to 177 Lu-DOTATATE PRRT in a 9-Year-Old Child With Metastatic Carotid Body Paraganglioma.
PubMed 文献 · Clin Nucl Med · 2023-11-16

本文报告一例9岁男孩转移性颈动脉体副神经节瘤,经68Ga-DOTANOC PET/CT发现颈部淋巴结和肺转移,接受177Lu-DOTATATE肽受体放射性核素治疗后3个周期转移灶显著改善,4个周期后达完全缓解,累计给药活度16.65 GBq。

要点

  • 9岁男孩转移性颈动脉体副神经节瘤经68Ga-DOTANOC PET/CT检出颈部淋巴结和肺转移。
  • 接受177Lu-DOTATATE肽受体放射性核素治疗3个周期后转移灶显著改善。
  • 4个周期后达完全缓解,累计给药活度16.65 GBq。

核心结论

  • 本病例提示177Lu-DOTATATE用于转移性颈动脉体副神经节瘤在肿瘤退缩和总体治疗反应方面结果积极。

研究设计与样本

  • 本文为个案报告,对象为一名9岁男孩,诊断为转移性颈动脉体副神经节瘤。

主要发现

  • 68Ga-DOTANOC PET/CT显示转移位于颈部淋巴结和肺。
  • 接受177Lu-DOTATATE肽受体放射性核素治疗3个周期后转移灶显著改善。
  • 4个周期后达完全缓解,累计给药活度16.65 GBq。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

We present a case involving a 9-year-old boy diagnosed with metastatic carotid body paraganglioma. The metastases were detected in cervical lymph nodes and lungs using 68 Ga-DOTANOC PET/CT imaging. The patient received peptide receptor radionuclide therapy with 177 Lu-DOTATATE. Following 3 treatment cycles, a significant improvement was observed in the metastatic lesions. After 4 cycles, the patient achieved a complete response, with a cumulative administered activity of 16.65 GBq during the therapy. This case underscores the effectiveness of using 177 Lu-DOTATATE in managing metastatic carotid body paraganglioma, offering promising results in terms of tumor regression and overall therapeutic response.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Yadav MP, Raju S, Ballal S, et al. Complete Response to 177 Lu-DOTATATE PRRT in a 9-Year-Old Child With Metastatic Carotid Body Paraganglioma. Clin Nucl Med. 2023. PMID: 37976428. doi:10.1097/RLU.0000000000004929

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。